NextCure, Inc. (NXTC) Misses Q3 EPS by 6c

NextCure, Inc. (NASDAQ: NXTC) reported Q3 EPS of ($0.41), $0.06 worse than the analyst estimate of ($0.35).

For earnings history and earnings-related data on NextCure, Inc. (NXTC) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• The Canadian Chrome Company Announces Update on the Process for Sale of the Company or Its Assets and Results of Annual and Special Shareholders' Meeting
• Buffalo Potash Announces Closing of C$14.01 Million First Tranche of Oversubscribed and Upsized C$14.85 Million Non-Brokered Private Placement